The purpose of this trial is to determine the safety and feasibility of the VentrAssist LVAD in providing circulatory support for patients who require an LVAD as a bridge to cardiac transplantation.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
30
University of Maryland Medical Center - Baltimore
Baltimore, Maryland, United States
University of Minnesota Medical Center - Fairview
Minneapolis, Minnesota, United States
New York Presbyterian Medical Center - Columbia
New York, New York, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Survival
Quality of life
Functional status
Neurocognitive function
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States